- Generic Name: hydromorphone hydrochloride injection
- Brand Name: DILAUDID-HP 500 mg/50 ml
- Drug Class: Opioid Analgesics
Description Of hydromorphone 2mg
What is DILAUDID-HP and how is it used?
hydromorphone 2mg is a prescription medicine used to treat the symptoms of Moderate-to-Severe Pain and Chronic Severe Pain. Dilaudid-HP may be used alone or with other medications.
DILAUDID-HP 500 mg/50 ml belongs to a class of drugs called Opioid Analgesics.
What are the possible side effects of hydromorphone 2mg?
hydromorphone 2mg may cause serious side effects including:
- difficulty breathing,
- swelling of your face, lips, tongue, or throat,
- breathing that slows or stops,
- blue colored lips,
- difficult to wake,
- noisy breathing,
- shallow breathing,
- breathing that stops during sleep,
- severe drowsiness,
- loss of appetite,
- worsening tiredness,
- fast heart rate,
- muscle stiffness,
- loss of coordination, and
Get medical help right away, if you have any of the symptoms listed above.
The most common side effects of Dilaudid-HP include:
- flushing (warmth, redness, or tingly feeling),
- dry mouth,
- mood changes,
- skin irritation, and
- hard lump where the injection was given
Tell the doctor if you have any side effect that bothers you or that does not go away.
These are not all the possible side effects of Dilaudid-HP. For more information, ask your doctor or pharmacist.
Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
WARNINGS WHEN CONSUMING DILAUDID-HP 500 mg/50 ml
RISK OF RESPIRATORY DEPRESSION, ABUSE, AND MEDICATION ERRORS
DILAUDID-HP 500 mg/50 ml INJECTION IS FOR USE IN OPIOID-TOLERANT PATIENTS ONLY
Patients considered opioid tolerant are those who are taking at least 60 mg oral morphine/day, 25 mcg transdermal fentanyl/hour, 30 mg oral oxycodone/day, 8 mg oral hydromorphone/day, 25 mg oral oxymorphone/day, or an equianalgesic dose of another opioid for one week or longer.
DILAUDID-HP INJECTION is a more concentrated solution of hydromorphone than DILAUDID INJECTION and is for use in opioid-tolerant patients only. Do not confuse DILAUDID-HP INJECTION with standard parenteral formulations of DILAUDID INJECTION or other opioids, as overdose and death could result.
DILAUDID INJECTION and DILAUDID-HP INJECTION contain hydromorphone, an opioid agonist and a Schedule II controlled substance with an abuse liability similar to other opioid analgesics. DILAUDID INJECTION and DILAUDID-HP INJECTION can be abused in a manner similar to other opioid agonists, legal or illicit. These risks should be considered when administering, prescribing, or dispensing DILAUDID INJECTION and DILAUDID-HP INJECTION in situations where the healthcare professional is concerned about increased risk of misuse, abuse, or diversion.
Schedule II opioid agonists, including morphine, oxymorphone, hydromorphone, oxycodone, fentanyl and methadone, have the highest potential for abuse and risk of producing fatal overdose due to respiratory depression. Ethanol, other opioids, and other central nervous system depressants (e.g., sedative-hypnotics, skeletal muscle relaxants) can potentiate the respiratory-depressant effects of hydromorphone and increase the risk of adverse outcomes, including death.